Home › Compare › FNCNF vs ABBV
FNCNF yields 13.14% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 6
Combined, FNCNF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FNCNF + ABBV for your $10,000?
Fincantieri S.p.A. operates in the shipbuilding industry worldwide. It operates in three segments: Shipbuilding; Offshore and Specialized Vessels; and Equipment, Systems and Infrastructure. The Shipbuilding segment designs and constructs cruise ships; expedition cruise vessels; naval vessels, such as aircraft carriers, destroyers, frigates, corvettes, patrol vessels, amphibious and logistic support ships, multirole and research vessels, special vessels, and submarines, as well as product lifecycle management, and training and assistance services; ship interiors comprising cabins, wet units, public areas, catering, glazing, and interior design solutions; and ship repairs, refitting, conversions, and refurbishment services. The Offshore and Specialized Vessels segment designs and constructs high-end offshore support vessels for offshore wind farms, and the oil and gas industry; specialized ships, such as cable-laying vessels and ferries; and unmanned vessels. The Equipment, Systems and Infrastructure segment offers energy generation/storage systems, such as electrical, electronic and electromechanical integrated systems, and entertainment systems; stabilization, propulsion, positioning, and power generation systems; and steam turbines, as well as designs and integrates systems with a focus on automation, cyber security, telecommunications, and critical infrastructures. This segment also is also involved in the design, construction, and assembly of steel structures on large project, including bridges, viaducts, airports, ports, maritime/hydraulic works, and large commercial and industrial buildings. The company provides dry-dock management; engineering, project, and supply chain management; information technology consultancy; mechanical products sale and after-sale; marine diesel engine maintenance; technological research and development; ship accommodation services; and charters boats, ships, and barges. The company was founded in 1959 and is headquartered in Trieste, Italy. Fincantieri S.p.A. is a subsidiary of CDP Equity S.p.A.
Full FNCNF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.